Comparison of Biphasic Insulin Aspart 70/30 With Anti-Diabetic Drugs in Subjects With Type 2 Diabetes

Completed · Phase 3

Conditions studied: Diabetes, Diabetes Mellitus, Type 2

In brief

This trial is conducted in the United States of America (USA). The purpose of this study is to test whether biphasic insulin aspart 70/30 is a safe and at least as effective alternative in combination with two oral anti-diabetics compared to the two oral anti-diabetics alone for the control of blood glucose.

Key facts

Study ID

NCT00097279

Run by

Novo Nordisk A/S

People needed

230

Starts

2004-08-01

Expected to finish

2005-08-01

Last updated by the study team

2017-01-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects with type 2 diabetes mellitus

Where it is running

• Novo Nordisk Investigational Site — Glendale, Arizona, United States
• Novo Nordisk Investigational Site — Phoenix, Arizona, United States
• Novo Nordisk Investigational Site — Searcy, Arkansas, United States
• Novo Nordisk Investigational Site — Burlingame, California, United States
• Novo Nordisk Investigational Site — Chula Vista, California, United States
• Novo Nordisk Investigational Site — Fullerton, California, United States
• Novo Nordisk Investigational Site — Los Angeles, California, United States
• Novo Nordisk Investigational Site — Redwood City, California, United States
• Novo Nordisk Investigational Site — Denver, Colorado, United States
• Novo Nordisk Investigational Site — New Britain, Connecticut, United States
• Novo Nordisk Investigational Site — Newark, Delaware, United States
• Novo Nordisk Investigational Site — Aventura, Florida, United States
• Novo Nordisk Investigational Site — Fort Myers, Florida, United States
• Novo Nordisk Investigational Site — Hollywood, Florida, United States
• Novo Nordisk Investigational Site — Lake Mary, Florida, United States
• Novo Nordisk Investigational Site — Melbourne, Florida, United States
• Novo Nordisk Investigational Site — Ocala, Florida, United States
• Novo Nordisk Investigational Site — Pembroke Pines, Florida, United States
• Novo Nordisk Investigational Site — Tallahassee, Florida, United States
• Novo Nordisk Investigational Site — West Palm Beach, Florida, United States
• Novo Nordisk Investigational Site — Atlanta, Georgia, United States
• Novo Nordisk Investigational Site — Columbus, Georgia, United States
• Novo Nordisk Investigational Site — Savannah, Georgia, United States
• Novo Nordisk Investigational Site — Boise, Idaho, United States
• Novo Nordisk Investigational Site — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.